MSB 5.24% $1.11 mesoblast limited

Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-44

  1. 111 Posts.
    lightbulb Created with Sketch. 56
    Nice to get past the first hurdle. Response on whether or not the FDA approves could come at any time between now and the 31at of July.

    If shorts start to play around they may find that they’ll get burned very quickly. As no one was really expecting this announcement today, given the performance of the stock price leading to this announcement

    GLTAH
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.